Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
131I-cG250 in Advanced Renal Carcinoma
NCT00003102Phase 2Completed
- Sponsor
- Ludwig Cancer Research
- Start
- Nov 1998
- Primary completion
- Apr 2000
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of 131I-cG250 in renal cell carcinoma (RCC), sponsored by Ludwig Cancer Research. Started Nov 1998; status: completed.
02
Drugs
131I-cG250
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00003102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003102.